## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($132.62)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Contact Levi & Korsinsky by December 2, 2025 to Join Class Action Against Molina Healthcare, Inc. (MOH)**
- Source: KLAS 8 News Now | 20251130T113100 | Neutral | Relevance: 99%
- Levi & Korsinsky LLP is urging investors who suffered losses on their Molina Healthcare, Inc. (MOH) investment between February 5, 2025, and July 23, 2025, to join a class action lawsuit. The lawsuit alleges that Molina Healthcare made false statements and concealed material adverse facts regarding its medical cost trend assumptions and financial guidance for fiscal year 2025. Investors have until December 2, 2025, to contact the firm to learn about their rights to potentially recover losses.

**2. Securities Lawsuit Alert: Molina Healthcare, Inc. (MOH) â€“ Contact Levi & Korsinsky Before December 2, 2025**
- Source: WTRF | 20251129T190100 | Neutral | Relevance: 99%
- Levi & Korsinsky LLP has issued a securities lawsuit alert for Molina Healthcare, Inc. (NYSE:MOH) shareholders who suffered losses between February 5, 2025, and July 23, 2025. The lawsuit alleges that Molina Healthcare made materially false and misleading statements regarding its medical cost trend assumptions and financial outlook. Shareholders are encouraged to contact Levi & Korsinsky by December 2, 2025, to learn about their rights to recover losses.

**3. MOH DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Molina Healthcare, Inc. Investors to Join the Class Action Lawsuit**
- Source: CBS 42 | 20251201T070000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC is reminding investors of Molina Healthcare, Inc. (MOH) to join a class action lawsuit filed against the company and its officers. The lawsuit alleges violations of federal securities laws for investors who purchased Molina securities between February 5, 2025, and July 23, 2025. The complaint claims that Molina failed to disclose material adverse facts regarding its medical cost trend assumptions and financial guidance for fiscal year 2025.

**4. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare**
- Source: Markets Financial Content | 20251129T131900 | Neutral | Relevance: 99%
- Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. (NYSE: MOH) on behalf of investors who suffered losses between February 5, 2025, and July 23, 2025. The lawsuit alleges Molina made misleading statements regarding its medical cost trends and financial guidance, leading to significant drops in stock price after two revised negative earnings outlooks in July 2025. Investors are encouraged to contact Faruqi & Faruqi to discuss their options and the December 2, 2025, deadline to seek the role of lead plaintiff.

**5. Investors who lost money on Molina Healthcare, Inc.(MOH) should contact The Gross Law Firm about pending Class Action - MOH**
- Source: Fox 59 | 20251201T134500 | Neutral | Relevance: 99%
- The Gross Law Firm has issued a notice for shareholders of Molina Healthcare, Inc. (NYSE: MOH) who incurred losses during the class period of February 5, 2025, to July 23, 2025. The firm is inviting affected investors to contact them regarding a pending class action lawsuit, alleging that Molina Healthcare made false statements and concealed material adverse facts about its medical cost trend assumptions and financial guidance. Shareholders have until December 2, 2025, to register for this class action to potentially be appointed as a lead plaintiff.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Wells Fargo | $165 | $231 | -29% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 39.5% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.7B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -0.62 |
| Forward P/E | 10.3 |
| Current P/E | 10.2 |
| YoY Growth | -0.8% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 3.4% to -0.5% (-3.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). Below SMA200 (0.60x), long-term trend not supportive. MACD histogram positive (2.36), confirming momentum. RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.45% (CS: 54) | Neutral |
| RSI_14 | 42.7 | Neutral |
| MACD Histogram | 2.36 | Bullish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 0.858x | Below |
| vs SMA200 | 0.605x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $145.00
- **Stop Loss:** $132.62 (8.5% risk)
- **Target:** $157.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 60
- **Position Value:** $8,700.00
- **Portfolio %:** 8.70%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*